Craft

Humasis

Stock Price

₩1.6 K

2024-10-29

Market Capitalization

₩228.6 B

2024-10-29

Revenue

₩25.4 B

FY, 2024

Humasis Summary

Company Summary

Overview
Humasis (휴마시스 모바일) is a company developing, manufacturing, and promoting in-vitro diagnostics (IVD). It offers IVD for the detection of the cardiac marker, fertility hormone, infectious disease, and tumor marker as well as provides rapid tests for home and laboratory use.
Type
Public
Status
Active
Founded
2000
HQ
Anyang, KR | view all locations
Website
http://www.humasis.com/
Cybersecurity rating
Sectors

Key People

  • Chung-Hak Cha

    Chung-Hak Cha, CEO

    Operating MetricsView all

    Patents and Patent Applications

    17

    Jul, 2020

    Products (Quantitative POCT Analyzer)

    19

    Jul, 2020

    Products (Fertility)

    10

    Jul, 2020

    LocationsView all

    1 location detected

    • Anyang, Gyeonggi-do HQ

      Korea (Republic of)

      88 Jeonpa-ro, Hogye 2(i)-dong, Dongan-gu

    Humasis Financials

    Summary Financials

    Revenue (Q3, 2025)
    ₩8.7B
    Gross profit (Q3, 2025)
    ₩1.7B
    Net income (Q3, 2025)
    (₩335.8M)
    Cash (Q3, 2025)
    ₩14.4B
    EBIT (Q3, 2025)
    (₩3.8B)
    Enterprise value
    $226.7B

    Footer menu